Cytisine
Cytisine has been studied in 15 papers since 2025: 4 observational studies in people, 1 in animals, 8 reviews; 14 in the past year. The newest paper, Nov 8, 2026: “Cytisine for Smoking Cessation: A Narrative Review of an Underutilized Therapy”.
2 new papers in 30 daysSee all 16 papers on cytisine
At a glance
The findings reach people, from one lab or study. 3 independent labs in 3 countries; 21 trials, none about aging, 7 with no results posted.
“The smoking cessation rate was 50.1% among cytisine users versus 8.1% for those receiving counseling alone (n = 2173) (p <0.05), adjusted OR: 14.53 (95% confidence interval [CI]: 11.67-18.08).”
None of its findings points the other way.
- 3 independent labs in 3 countries
- 21 trials, none about aging, 7 with no results posted
- Funders: Istituti di Ricovero e Cura a Carattere Scientifico and 3 more
- 13 of 21 trials sponsored by its developers
- Humans4
- Animals1
- In silico1
What did studies of cytisine find?
7Studies of cytisine measured 7 outcomes; the most studied is smoking cessation (3 studies).
Smoking cessation
upin humans2upin reviews1
3 studies
Smoking cessation
upin humans2upin reviews1
Cytisine increases smoking cessation in humans (Compared with placebo).
“Randomized trials show that cytisine has greater smoking-cessation efficacy than placebo.”
ReviewCompared with placebo
Cytisine for Smoking Cessation: A Narrative Review of an Underutilized Therapy
Pulmonary therapy
Cytisine improves smoking cessation in humans.
“Two Phase 3 randomized double-blind placebo-controlled trials have demonstrated cytisinicline's efficacy and safety for smoking cessation in US adults.”
Review
An evaluation of cytisinicline for smoking cessation in adult smokers
Expert opinion on pharmacotherapy
Cytisine improves smoking cessation (early trials).
“Cytisine, a plant-derived partial nicotinic agonist, has shown effectiveness in early trials and may offer a favorable tolerability and cost profile.”
Reviewearly trials
Emerging and Established Pharmacotherapies for Smoking Cessation: A Review
Cardiology in review
Cigarette consumption
downin humans1
1 study
Cigarette consumption
downin humans1
Cytisine decreases cigarette consumption in humans (vs counseling alone) (23.4% versus 10.0%).
“The cytisine group reported a greater reduction in cigarette consumption (23.4% versus 10.0%, p <0.0001).”
Human trialvs counseling alone1.5 mg on an escalating and deescalating schedulen = 3,548
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Smoking abstinence
upin humans1OR 14.53
1 study
Smoking abstinence
upin humans1OR 14.53
Cytisine increases smoking abstinence in humans within lung cancer screening, vs counseling alone (OR 14.53 (95% CI 11.67-18.08)).
“The smoking cessation rate was 50.1% among cytisine users versus 8.1% for those receiving counseling alone (n = 2173) (p <0.05), adjusted OR: 14.53 (95% confidence interval [CI]: 11.67-18.08).”
Human trialwithin lung cancer screening, vs counseling alone1.5 mg on an escalating and deescalating schedulen = 3,548
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Dyspnea
upin humans1
1 study
Dyspnea
upin humans1
Cytisine is linked with better dyspnea in humans.
“Improvement in dyspnea was reported more frequently among cytisine users.”
Humansn = 113
Tobacco induced diseases
Years of life lost
downin silico1−11%
1 study
Years of life lost
downin silico1−11%
Cytisine decreases years of life lost in silico (-10.9%).
“In a scenario including the transition probabilities from the TTP cohort, this alternative would result in a 10.9% reduction in YLL”
In silico
BMJ open
Smoking
downin humans1
1 study
Smoking
downin humans1
Cytisine decreases smoking in humans.
“Owing to its efficacy, tolerability profile, and low cost, cytisine represents a valuable addition to the smoking cessation toolkit.”
Review
Rediscovering cytisine: Why the WHO's decision matters for global public health
iScience
CHRNA3
upin mouse cells1
1 study
CHRNA3
upin mouse cells1
Cytisine increases CHRNA3 in mouse cells.
“nicotine and cytisine increased it”
CellsHT22 cells
Cells
What is cytisine linked with?
2Studies link cytisine with 2 measures: reported adverse events and smoking cessation.
Reported adverse events
downin humans1
1 study
Reported adverse events
downin humans1
Cytisine is associated with reported adverse events in humans (Compared with varenicline in direct comparative trials).
“Cytisine is generally well tolerated and has been associated with fewer reported adverse events than varenicline in direct comparative trials.”
ReviewCompared with varenicline in direct comparative trials
Cytisine for Smoking Cessation: A Narrative Review of an Underutilized Therapy
Pulmonary therapy
Smoking cessation
upin humans1
1 study
Smoking cessation
upin humans1
Cytisine is associated with smoking cessation in humans (58.2% vs 39.1%, p=0.046).
“Cytisine use was more frequent among patients who achieved smoking cessation (58.2% vs 39.1%, p=0.046)”
Humansn = 113
Tobacco induced diseases
Has cytisine been tested in people?
0 of 21 about agingYes: 4 observational studies in people have been published, and 20 trials are registered.
In trials
Phase 4Completed18 trials
Phase 4Completed3 trials
Motor Activity
Phase 4Status unknown2 trials
Phase 4Completed1 trial
Phase 3Active, not recruiting2 trials
Cigarette smoking
Phase 2Recruiting1 trial
All 9Fewer
Who is developing cytisine?
1 company: Achieve Life Sciences.
- Companies
- Achieve Life SciencesPhase 3smoking cessation, vaping cessation
Trial sponsors
Company12 trialsPhase 32,733 people
1 trialPhase 41,307 people
Maimónides Biomedical Research Institute of Córdoba
1 trialPhase 4150 people
Centre for Addiction and Mental Health
1 trialPhase 420 people
2 trialsPhase 3714 people
Population Health Research Institute
1 trialPhase 31,720 people
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
1 trialPhase 22,000 people
University of California Los Angeles
1 trialPhase 264 people